CADL

Candel Therapeutics (CADL)

About Candel Therapeutics (CADL)

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Details

Daily high

$8.86

Daily low

$8.38

Price at open

$8.68

52 Week High

$9.57

52 Week Low

$4.35

Market cap

623.5M

Dividend yield

0.00%

Volume

2,809

Avg. volume

2.2M

P/E ratio

-8.70

Candel Therapeutics News